An Open-Label, Dose Escalation Study to Evaluate the Safety and the Pharmacokinetics of Oral PRX-112

Clinical trial NCT02107846 · COMPLETED

Trial details

NCT number: NCT02107846
Sponsor: Protalix
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gaucher Disease

Start date: 2014-04-01
Primary completion: 2015-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.